about
The human Major Histocompatibility Complex as a paradigm in genomics researchAllele-specific repression of lymphotoxin-alpha by activated B cell factor-1The chromosome 6p22 haplotype associated with dyslexia reduces the expression of KIAA0319, a novel gene involved in neuronal migrationGenetics of gene expression in immunity to infectionSystematic identification of trans eQTLs as putative drivers of known disease associationsXGR software for enhanced interpretation of genomic summary data, illustrated by application to immunological traits.A common variant associated with dyslexia reduces expression of the KIAA0319 geneAn integrated expression phenotype mapping approach defines common variants in LEP, ALOX15 and CAPNS1 associated with induction of IL-6Leprosy and the adaptation of human toll-like receptor 1.An integrated approach to defining genetic and environmental determinants for major clinical outcomes involving vitamin D.Insights from early experience of a Rare Disease Genomic Medicine Multidisciplinary Team: a qualitative study.Inherited variability of tumor necrosis factor production and susceptibility to infectious disease.Investigation of a possible extended risk haplotype in the IL23R region associated with ankylosing spondylitis.An allele-specific gene expression assay to test the functional basis of genetic associations.Innate immune activity conditions the effect of regulatory variants upon monocyte gene expressionAllele-specific transcription of the asthma-associated PHD finger protein 11 gene (PHF11) modulated by octamer-binding transcription factor 1 (Oct-1).A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolutionGenetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles.Genetic determinants of HSP70 gene expression following heat shock.Major histocompatibility complex genomics and human disease.Genomic mapping of the MHC transactivator CIITA using an integrated ChIP-seq and genetical genomics approach.Approaches for establishing the function of regulatory genetic variants involved in disease.Transcriptomic profiling facilitates classification of response to influenza challenge.Increased prevalence of sex chromosome aneuploidies in specific language impairment and dyslexiaFunctional implications of genetic variation in non-coding DNA for disease susceptibility and gene regulation.Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study.Regulatory polymorphisms underlying complex disease traits.A common haplotype of the TNF receptor 2 gene modulates endotoxin tolerance.Cell Specific eQTL Analysis without Sorting Cells.Resolving the variable genome and epigenome in human disease.Genomic modulators of gene expression in human neutrophilsGenome-wide analysis identifies a role for common copy number variants in specific language impairmentFactors influencing success of clinical genome sequencing across a broad spectrum of disordersApplication of whole genome and RNA sequencing to investigate the genomic landscape of common variable immunodeficiency disorders.Origins of magic: review of genetic and epigenetic effectsGenetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus.Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes.A functional AT/G polymorphism in the 5'-untranslated region of SETDB2 in the IgE locus on human chromosome 13q14Genomic modulators of the immune responseGenomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study
P50
Q24596895-013D75BA-200C-4ACE-9CC6-4E3A4808CA08Q28253492-6DC5ABDE-73D9-4F17-BC8E-E46D2EA47984Q28306226-F6E81E37-D7A4-4AD7-AE0C-3F7CABA5029EQ28647767-BB55271E-B504-4A36-9425-C24F97253239Q28659854-8B9A0A32-B583-4E8B-A8FD-BBF1C9FE0142Q31148615-6E8658EF-5E8A-41A9-9E29-89CCFB592901Q33422937-4F92FB76-8E35-4F43-BC5F-1E0F3BB7F904Q33594234-C52727C9-1642-42B9-A0DE-8452F2C220A2Q33628811-8BCDE378-1F42-4E79-B331-50A1EB377951Q33651712-64639726-8598-4EDC-8F43-0951A4998A9CQ33665907-5B3B0A6B-3BD5-4259-879D-2B712AD24513Q33694069-F84D68D8-D47B-4AE8-89E6-DA744822D923Q33701544-FD190036-39C2-435C-88E6-BD02E505B44DQ33749322-69B491E5-6260-44A3-AF98-219AE6C786A8Q33783132-122D42E6-2F68-4E9C-8435-D86F58D5F2B3Q33820424-CC4A1527-F304-4F3C-886F-E80FC1554AA9Q34153604-8068A6EB-FFD0-4DCC-B315-EAE56DC9820DQ34263565-3FC87F11-7231-460D-8568-EFA9AA922C07Q34341163-5B038A23-D72C-44AD-B3CD-F0E5B2C19DC8Q34359146-92334AD6-B9BA-403B-8677-7B906EEE16A0Q34568890-8C726B6C-7734-44A7-A8E9-A8CD16A753EBQ34624885-AB7A3F54-3ED3-4863-A411-5DE9CE31EC0EQ34798503-4607AE51-63B7-4460-8640-66A5585C76D3Q34946965-14C7B3D3-4F0E-434C-B837-9E64EDCC7A3BQ35039250-2E292E29-12DF-4B37-B9E8-6F9CCE83FDBDQ35041304-D0963F2C-FCA0-4CF3-B9D3-4277667D523CQ35094167-576EC96E-92E1-4809-8ACD-B4F526B8C300Q35536193-C3A7B72C-308D-4856-9701-A5CF1CFBC4DBQ35587187-6B8F8502-AAC2-473A-BF9A-E71106074DE8Q35640065-74656CC1-878B-43E1-A0A6-CD41FD3E0943Q35864995-0BCFD216-1F60-48ED-93A9-0DD28ED09640Q36116694-B43C9206-EBCD-4CD1-9A5D-1E238C207D11Q36147983-FC68C35A-9111-4BF2-BFAF-A61E086AA50FQ36147997-04200AA6-3677-44E7-9ECE-E27837311120Q36294687-F071D0C2-10EE-4F38-8B5C-6111D55B129CQ36343939-73E6553D-CA68-4ED5-BCCF-49C45CC3C1CFQ36540944-E41764CC-8730-4B6B-8693-959A78CBF0F6Q36605745-65B106A0-33A4-4486-B8B9-9A1EB83294C1Q36708347-59B4175D-835B-4D23-9FC7-DAB49BDECD72Q36764754-A62CADC2-7CFA-4DA8-A020-5E4806764BB1
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Julian C Knight
@ast
Julian C Knight
@en
Julian C Knight
@es
Julian C Knight
@nl
Julian C Knight
@sl
type
label
Julian C Knight
@ast
Julian C Knight
@en
Julian C Knight
@es
Julian C Knight
@nl
Julian C Knight
@sl
altLabel
Julian Knight
@en
prefLabel
Julian C Knight
@ast
Julian C Knight
@en
Julian C Knight
@es
Julian C Knight
@nl
Julian C Knight
@sl
P106
P21
P31
P496
0000-0002-0377-5536